Sergio Lilla

Sergio Lilla

Auto-generated profile, based on publicly available information

Sergio Lilla

CRUK Scotland Institute

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
FKFernanda G. Kugeratski
Fernanda G. Kugeratski
KHKelly Hodge
Kelly Hodge
SLSergio Lilla
Sergio Lilla
KMKathleen M. McAndrews
Kathleen M. McAndrews
XZXunian Zhou
Xunian Zhou
RKRaghu Kalluri
Raghu Kalluri

20 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JRJiska van der Reest
Jiska van der Reest
SLSergio Lilla
Sergio Lilla
LZLiang Zheng
Liang Zheng
SZSara Zanivan
Sara Zanivan
EGEyal Gottlieb
Eyal Gottlieb
Reactive oxygen species (ROS) are increasingly recognised as important signalling molecules through oxidation of protein cysteine residues. Comprehensive identification of redox-regulated proteins and pathways is crucial to understand ROS-mediated events. Here, we present stable isotope cysteine labelling with iodoacetamide (SICyLIA), a mass spectrometry-based workflow to assess proteome-scale cysteine oxidation. SICyLIA does not require enrichment steps and achieves unbiased proteome-wide sensitivity. Applying SICyLIA to diverse cellular models and primary tissues provides detailed insights into thiol oxidation proteomes. Our results demonstrate that acute and chronic oxidative stress causes oxidation of distinct metabolic proteins, indicating that cysteine oxidation plays a key role in the metabolic adaptation to redox stress. Analysis of mouse kidneys identifies oxidation of proteins circulating in biofluids, through which cellular redox stress can affect whole-body physiology. Obtaining accurate peptide oxidation profiles from complex organs using SICyLIA holds promise for future analysis of patient-derived samples to study human pathologies.

27 June 2022 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
EKEmily J. Kay
Emily J. Kay
KPKarla Paterson
Karla Paterson
CRCarla Riera-Domingo
Carla Riera-Domingo
DSDavid Sumpton
David Sumpton
JDJ. Henry M. Däbritz
J. Henry M. Däbritz
SZSara Zanivan
Sara Zanivan
Elevated production of collagen-rich extracellular matrix is a hallmark of cancer-associated fibroblasts (CAFs) and a central driver of cancer aggressiveness. Here we find that proline, a highly abundant amino acid in collagen proteins, is newly synthesized from glutamine in CAFs to make tumour collagen in breast cancer xenografts. PYCR1 is a key enzyme for proline synthesis and highly expressed in the stroma of breast cancer patients and in CAFs. Reducing PYCR1 levels in CAFs is sufficient to reduce tumour collagen production, tumour growth and metastatic spread in vivo and cancer cell proliferation in vitro. Both collagen and glutamine-derived proline synthesis in CAFs are epigenetically upregulated by increased pyruvate dehydrogenase-derived acetyl-CoA levels. PYCR1 is a cancer cell vulnerability and potential target for therapy; therefore, our work provides evidence that targeting PYCR1 may have the additional benefit of halting the production of a pro-tumorigenic extracellular matrix. Our work unveils new roles for CAF metabolism to support pro-tumorigenic collagen production.

19 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABArnaud Blomme
Arnaud Blomme
CFCatriona A. Ford
Catriona A. Ford
EMErnest Mui
Ernest Mui
RPRachana Patel
Rachana Patel
CNChara Ntala
Chara Ntala
HLHing Leung
Hing Leung
Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) progression. In this study, we perform a comprehensive unbiased characterisation of LNCaP cells chronically exposed to multiple AR inhibitors (ARI). Combined proteomics and metabolomics analyses implicate an acquired metabolic phenotype common in ARI-resistant cells and associated with perturbed glucose and lipid metabolism. To exploit this phenotype, we delineate a subset of proteins consistently associated with ARI resistance and highlight mitochondrial 2,4-dienoyl-CoA reductase (DECR1), an auxiliary enzyme of beta-oxidation, as a clinically relevant biomarker for CRPC. Mechanistically, DECR1 participates in redox homeostasis by controlling the balance between saturated and unsaturated phospholipids. DECR1 knockout induces ER stress and sensitises CRPC cells to ferroptosis. In vivo, DECR1 deletion impairs lipid metabolism and reduces CRPC tumour growth, emphasizing the importance of DECR1 in the development of treatment resistance.

2 February 2023 in Nature Cancer
Verified
Journal Article
Open access
PDF file
PAPatricia Altea-Manzano
Patricia Altea-Manzano
GDGinevra Doglioni
Ginevra Doglioni
YLYawen Liu
Yawen Liu
ACAlejandro M. Cuadros
Alejandro M. Cuadros
ENEmma Nolan
Emma Nolan
SFSarah-Maria Fendt
Sarah-Maria Fendt
Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver are lipid-rich environments. Moreover, we observe that pre-metastatic niche formation increases palmitate availability only in the lung, whereas a high-fat diet increases it in both organs. In line with this, targeting palmitate processing inhibits breast cancer-derived lung metastasis formation. Mechanistically, breast cancer cells use palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. Concomitantly, lysine acetyltransferase 2a expression is promoted by palmitate, linking the available acetyl-CoA to the acetylation of the nuclear factor-kappaB subunit p65. Deletion of lysine acetyltransferase 2a or carnitine palmitoyltransferase 1a reduces metastasis formation in lean and high-fat diet mice, and lung and liver metastases from patients with breast cancer show coexpression of both proteins. In conclusion, palmitate-rich environments foster metastases growth by increasing p65 acetylation, resulting in a pro-metastatic nuclear factor-kappaB signaling.

5 February 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
FKFernanda G. Kugeratski
Fernanda G. Kugeratski
SASamuel J. Atkinson
Samuel J. Atkinson
LNLisa J. Neilson
Lisa J. Neilson
SLSergio Lilla
Sergio Lilla
JKJohn R. P. Knight
John R. P. Knight
SZSara Zanivan
Sara Zanivan
Analysis of the cancer-associated fibroblast secretome identifies an angiogenesis-promoting factor.